Panacea Biotec Pharma Limited Appoints Krishan Kumar Jalan as Independent Director, Reappoints Manjula Upadhyay
Panacea Biotec Limited reported that the Board of Directors of its material wholly owned subsidiary, Panacea Biotec Pharma Limited (PBPL), approved key appointments and reappointments for independent directors. These decisions were formalized in a board meeting held on May 29, 2026.The board approved the appointment of Mr. Krishan Kumar Jalan as an additional director. Mr. Jalan will serve in the capacity of a non-executive independent director, not liable to retire by rotation. His tenure is set to commence on July 01, 2026, and continue until February 13, 2030, subject to shareholder approval.
Separately, the board also approved the re-appointment of Mrs. Manjula Upadhyay. She will continue serving as a non-executive independent director, not liable to retire by rotation, for a term of five consecutive years. Her term is effective from July 23, 2026, to July 22, 2031, also subject to shareholder approval.
Director Profiles and Details
Details regarding the appointed and reappointed directors are as follows:| Director Name | DIN | Key Appointment/Action | Tenure Start | Tenure End |
|---|---|---|---|---|
| Mr. Krishan Kumar Jalan | 01767702 | Additional Independent Director at PBPL | July 01, 2026 | February 13, 2030 |
| Mrs. Manjula Upadhyay | 07137968 | Re-appointment as Independent Director at PBPL | July 23, 2026 | July 22, 2031 |
Biographical Highlights
The board records provided detailed profiles for both individuals:Mr. Krishan Kumar Jalan
Mr. Jalan, aged about 68 years, brings extensive experience from the Indian Administrative Service (IAS) over 35 years. His educational background includes B.Sc. Honours and M.Sc. in Mathematics, M.Phil. in Mathematics, and M. Phil. in Public Administration. He also holds a Master of Social Science in Development Administration from the University of Birmingham, UK, and attended various short-term courses, including one at Columbia University. In addition to his administrative background, he currently serves as an independent director for entities such as PNC Infratech Ltd., Titagarh Rail Systems Ltd., Pipan Oils Ltd., and Asit C Mehta Financial Services Limited.
Mrs. Manjula Upadhyay
Mrs. Upadhyay is a practicing lawyer with approximately 37 years of experience, specializing particularly in labour laws. Her current directorships include The Delhi Floor Mills Company Ltd. and DTC India Ltd. She also serves as the Managing Partner of MR Lex Corp LLP, which provides consultancy services to several companies within the Panacea Group.
Both Mr. Jalan and Mrs. Upadhyay are noted as not being related to any other director and are not debarred from holding the office of Director by virtue of any SEBI Order or other authority.
PANACEABIO Stock Price Movement
Panacea Biotec Limited shares today slipped by 0.52% to settle at ₹412.85. The stock saw a trading volume of 99,419 shares, finishing its session within a daily range of ₹409.05 to ₹427.4.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.